Uroxatral Sanofi Synthelabo - Treatment for Benign Prostatic Hyperplasia (BPH)
Uroxatral is an alpha-adrenergic blocker used in adult men to treat benign prostatic hyperplasia (BPH).Posted: June 2003
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
